Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.11

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.11), versus ($0.05) reported last year. Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.16 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Seacoast Banking (SBCF) PT Raised to $34 at Piper Sandler
• Syensqo SA (SYENS:BB) PT Raised to EUR74 at Deutsche Bank